Impact of Melatonin, Zaleplon, Zopiclone, and Temazepam on Psychomotor Performance

Aviation Space and Environmental Medicine

Volumn 74, Issue 12, 2003, Pages 1263-1270

  Paul, Michel A ^a   Gray, Gary ^a   Kenny, Gord ^a   Pigeau, Ross A ^a  

^a DEFENCE RESEARCH AND DEVELOPMENT CANADA   (Canada)

Author keywords

Chronobiology; Hypnotics; Military operations; Performance

Indexed keywords

ACETAMIDE DERIVATIVE; ANTIOXIDANT; ANXIOLYTIC AGENT; HYPNOTIC AGENT; HYPNOTIC SEDATIVE AGENT; LONG ACTING DRUG; MELATONIN; PIPERAZINE DERIVATIVE; PLACEBO; PYRIMIDINE DERIVATIVE; STARNOC; TEMAZEPAM; ZALEPLON; ZOPICLONE;

ADULT; ALERTNESS; ANALYSIS OF VARIANCE; ARITHMETIC; ARTICLE; BLOOD SAMPLING; CHRONOBIOLOGY; CLINICAL PROTOCOL; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG BLOOD LEVEL; DRUG DOSE REGIMEN; DRUG EFFECT; DRUG HALF LIFE; FATIGUE; FEMALE; HALF LIFE TIME; HUMAN; HUMAN EXPERIMENT; LOGIC; MALE; MENTAL PERFORMANCE; MILITARY PHENOMENA; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; PARAMETER; PSYCHOMOTOR PERFORMANCE; QUANTITATIVE ANALYSIS; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; SINGLE DRUG DOSE; SLEEP; SLEEP INDUCTION; SLEEP PATTERN; SLEEP WAKING CYCLE; SOLDIER; TASK PERFORMANCE;

ACETAMIDES; ADMINISTRATION, ORAL; ADULT; ANTI-ANXIETY AGENTS; ANTIOXIDANTS; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; FATIGUE; FEMALE; HALF-LIFE; HUMANS; HYPNOTICS AND SEDATIVES; MALE; MELATONIN; MIDDLE AGED; MILITARY PERSONNEL; PIPERAZINES; PLACEBOS; PSYCHOMOTOR PERFORMANCE; PYRIMIDINES; SLEEP; TASK PERFORMANCE AND ANALYSIS; TEMAZEPAM;

EID: 0347384017     PISSN: 00956562     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Arendt J, Aldhous M, English J, et al. Some effects of jet-lag and their alleviation by melatonin. Ergonomics 1987; 30:1379-93.
2. Baddley AD. A 3-min reasoning test based on grammatical transformation. Psychon Sci 1968; 10:341-2.
3. Begg A, Drummond G, Tiplady B. Effects of temazepam on memory and psychomotor performance: a dose-response study. Hum Psychopharmacol 2001; 16:475-80.
4. Billiard M, Besset A, de Lustrac C, et al. Effets de la zopiclone sur le sommeil, la somnolence diurne et les performances nocturnes et diurnes chez le volontaire sain. Neurophysiol Clin 1989; 19:131-43.
5. Broadhurst A, Cushnagan RC. Residual effects of zopiclone (Imovane). Sleep 1987; 10(Suppl 1):48-53.
6. Brown GM. Melatonin in pyschiatric and sleep disorders: therapeutic implications. Pharmacol Pathophysiol 1995; 3:209-26.
7. Caldwell JL, Prazinko BF, Rowe T, et al. Improving daytime sleep with temazepam as a countermeasure for shift lag. Aviat Space Environ Med 2003; 74:153-63.
8. Comperatore CA, Lieberman HR, Kirby AW, et al. Melatonin efficacy in aviation missions requiring rapid deployment and night operations. Aviat Space Environ Med 1996; 67:520-4.
9. Dollins AB, Lynch HJ, Wurtman RJ, et al. Effect of pharmacological daytime doses of melatonin on human mood and performance. Pyschopharmacol 1993; 112:490-6.
10. Gaillot J, Heusse D, Houghton GW, et al. Pharmacokinetics and metabolism of zopiclone. Pharmacol 1983; 27(Suppl 2):76-91.
11. Gillin JC, Byerley WF. Drug therapy: The diagnosis and management of insomnia. N Engl J Med 1990; 322:239-48.
12. Greenblatt DJ, Divoll M, Abernethy DR, et al. Clinical pharmacokinetics of the newer benzodiazepines. Clin Pharmacokinet 1983;233-52.
13. Greenblatt DJ, Harmatz JS, von Moltke LL, et al. Comparative kinetics and dynamics of zaleplon, zolpidem, and placebo. Clin Pharmacol Ther 1998; 64:553-61.
14. Hemmeter U, Muller M, Bischof R, et al. Effect of zopiclone and temazepam on sleep EEG parameters, psychomotor, and memory function in healthy elderly volunteers. Psychopharmacol 2000; 147:384-96.
15. Heslegrave RJ, Angus RG. The effects of task duration and work-session location on performance degradation induced by sleep loss and sustained cognitive work. Behav Res Methods Inst Comp 1985; 17:592-603.
16. Hindmarch I. Effects of hypnotic and sleep-inducing drugs on objective assessments of human psychomotor performance and subjective appraisals of sleep and early morning behaviour. Br J Clin Pharmac 1979; 8(Suppl):43-6.
17. Hindmarch I, Patat A, Stanley N, et al. Residual effects of zaleplon and zolpidem following middle of the night administration five hours to one hour before awakening. Hum Psychopharmacol Clin Exp 2001; 16:159-67.
18. King DG. Benzodiazepines, amnesia, and sedation: theoretical and clinical issues and controversies. Hum Psychopharmacol Clin Exp 1992; 7:79-87.
19. Kunsman GW, Manno JE, Przekop MA, et al. The effects of temazepam and ethanol on human psychomotor performance. Eur J Clin Pharmacol 1992; 43:603-11.
20. Ladner M, Denny SC. A double-blind study to establish the residual effects of zopiclone on performance in healthy man. In: Nicholson AN, Scholsberg A, Dreyfus JF, eds. Zopiclone: a third generation of hypnotics. Basel, Switzerland: Karger; 1983:98-108.
21. Lieberman HR, Waldhauser F, Garfield G, et al. Effects of melatonin on human mood and performance. Brain Res 1984; 323:201-7.
22. Nicholson AN. Hypnotics, and air operations. In: Sustained intensive air operations: physiological and performance aspects. AGARD Conference Proceedings, 338. Neuilly-sur-Seine, France: Advisory Group for Aerospace Research and Development; 1983.
23. Parrino L, Terzano MG. Polysomnographic effects of hypnotic drugs. A review. Psychopharmacol 1996; 126:1-16.
24. Paul MA, Brown G, Buguet A, et al. Melatonin, and zopiclone as pharmacologic aids to facilitate crew rest. Aviat Space Environ Med 2001; 72:974-84.
25. Pigeau R, Naitoh P, Buguet A, et al. Modafinil, d-amphetamine, and placebo during 64 hours of sustained mental work: Effects on mood, fatigue, cognitive performance, and body temperature. J Sleep Res 1995; 4:212-28.
26. Porcu S, Bellatreccia A, Ferrara M, Casagrande M. Performance, ability to stay awake, and tendency to fall asleep during the night after a diurnal sleep with temazepam or placebo. Sleep 1997; 20:535-41.
27. Rickels K. Clinical trials of hypnotics. J Clin Psychopharmacol 1983; 3:133-9.
28. Rush CR, Frey JM, Griffiths RR. Zaleplon and triazolam in humans: acute behavioral effects and abuse potential. Psychopharmacol (Berl) 1999; 145:39-51.
29. Saano V, Hansen PP, Paronen P. Interactions and comparative effects of zopiclone, diazepam, and lorazepam on psychomotor performance and on elimination pharmacokinetics in healthy volunteers. Pharmacol Toxicol 1992; 70:135-9.
30. Subhan Z, Hindmarch I. Effects of zopiclone and benzodiazepine hypnotics on search in short-term memory. Neuropsychobiology 1984; 12:244-8.
31. Tiplady B, Faineteau H, Loganathan A, et al. Effects of ethanol and temazepam on performance in memory and psychomotor task: a dose-response comparison. Hum Psychopharmacol Clin Exp 1998; 13:285-91.
32. Vermeeren A, Danjou PE, O'Hanlon JF. Residual effects of evening and middle-of-the-night administration of zaleplon 10 and 20 mg on memory and actual driving performance. Hum Psychopharmacol Clin Exp 1998; 13(Suppl):S98-107.
33. Warot D, Bensimon G, Danjou P, Puech AJ. Comparative effects of zopiclone, triazolam, and placebo on memory and psychomotor performance in healthy volunteers. Fundam Clin Pharmacol 1987; 1:145-52.
34. Weinberg H, Jantzen KJ, Cheyne D, et al. Jetlag, gamma activity, and managing pilot fatigue. Fatigue in transportation workshop, multimodal issues and solutions. Ottawa: Transport Canada; 1998. Transport Canada conference proceedings TP 13375.
35. Wilkinson RT, Houghton D. Portable four-choice reaction time test with magnetic tape memory. Behav Res Methods Inst Comp 1975; 7:441-6.
36. Woods JH, Katz JL, Winger G. Benzodiazepines: use, abuse, and consequences. Pharmacol Rev 1992; 44:151-347.
37. Wynn VT, Arendt J. Effect of melatonin on the human electrocardiogram and simple reaction time responses. J Pineal Res 1988; 5:427-35.